Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil to New Highs This Summer MidAmerica Apartment Communities MAA Faces Lower Rent Growth Outlook After Scotiabank Downgrade Vertiv Expands Power Protection Portfolio with Launch of Vertiv PowerUPS 100 Standby Series in North America Bolivia Political Risk Escalates as Ministers Convoy Ambushed During Economic Policy Unrest Shell Capital Return Strategy Reemerges as Key Investor Focus CVS Caremark to Cover Eli Lillys GLP1 Drugs Foundayo and Zepbound Expanding Access for Millions JBS Q1 2026 Earnings EPS Miss Pressures Shares as Cost Headwinds Persist Innovative Eyewear Inc LUCY Q1 2026 Earnings EPS Surprise Lifts Sentiment Despite Revenue Uncertainty CLDX Q1 2026 Earnings Celldex Reports EPS Miss Amid EarlyStage Pipeline Progress Donaldson Company Q1 2026 Earnings EPS Miss Weighs on Sentiment Stock Still Gains Porch Group Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Share Appreciation HIND Q1 2026 Earnings EPS Beat Despite Limited Revenue Visibility ABVC BioPharma Surges 13 Key Levels and Potential Scenarios Nuveen Dynamic Municipal Opportunities Fund NDMO Creeps Higher Consolidating in a Narrow Range Entegris ENTG Edges Lower Amid Broader Semiconductor Sector Weakness Beeline Holdings Inc BLNE Edges Lower Testing Proximity to Key Support Arrive AI Inc ARAI Holds Near Support After Minor Decline Wall Street Maintains Cautious Stance on Snap Inc Following Latest Earnings Report ADAMH Q1 2026 Earnings Strong EPS Surprise of 75 Driven by Trust Income Avis Budget Group CAR Edges Lower as Shares Test Key Support Levels VALE Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Equifax Q1 2026 Earnings EPS Beats Estimates by 83 Amid Steady Operational Execution LILAK Q1 2026 Earnings Heavy EPS Miss Shakes Investor Confidence GREE Q1 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Discontinuation WEBTOON Entertainment Inc WBTN Q1 2026 Earnings EPS Beat on Cost Discipline Revenue Visibility Remains Limited ZNB Q4 2011 Earnings EPS Surges 5232 Above Estimates Stock Declines 274 Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment